Tag Archives: ILIAS Biologics

Engineered extracellular vesicles carrying srIκB reduce inflammation in a non-human primate model of chorioamnionitis, offering a promising new direction for treating pregnancy-related inflammatory...

ILIAS Biologics, a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).A patent for ILIAS's exosome engineering was...